Literature DB >> 30817233

Advances in synthetic lung surfactant protein technology.

Frans J Walther1,2, Larry M Gordon2, Alan J Waring1,2.   

Abstract

Keywords:  Preterm infants; respiratory distress syndrome (RDS); surfactant protein B (SP-B); surfactant protein C (SP-C); synthetic lung surfactant

Year:  2019        PMID： 30817233     DOI： 10.1080/17476348.2019.1589372

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN： 1747-6348            Impact factor:   3.772


× No keyword cloud information.
  8 in total

Review 1.  Surfactant protein disorders in childhood interstitial lung disease.

Authors:  Jagdev Singh; Adam Jaffe; André Schultz; Hiran Selvadurai
Journal:  Eur J Pediatr       Date:  2021-04-11       Impact factor: 3.183

2.  All-Atom Molecular Dynamics Simulations of Dimeric Lung Surfactant Protein B in Lipid Multilayers.

Authors:  Nicholas A S Robichaud; Mohammad Hassan Khatami; Ivan Saika-Voivod; Valerie Booth
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

Review 3.  Coronavirus-Induced Host Cubic Membranes and Lipid-Related Antiviral Therapies: A Focus on Bioactive Plasmalogens.

Authors:  Yuru Deng; Angelina Angelova
Journal:  Front Cell Dev Biol       Date:  2021-03-12

Review 4.  Pulmonary surfactant as a versatile biomaterial to fight COVID-19.

Authors:  Lore Herman; Stefaan C De Smedt; Koen Raemdonck
Journal:  J Control Release       Date:  2021-11-20       Impact factor: 9.776

5.  Efficacy, dose-response, and aerosol delivery of dry powder synthetic lung surfactant treatment in surfactant-deficient rabbits and premature lambs.

Authors:  Frans J Walther; Alan J Waring; Monicah Otieno; Robert M DiBlasi
Journal:  Respir Res       Date:  2022-04-04

Review 6.  Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome.

Authors:  Frans J Walther; Alan J Waring
Journal:  Front Pediatr       Date:  2022-06-15       Impact factor: 3.569

7.  Surfactant-based prophylaxis and therapy against COVID-19: A possibility.

Authors:  K Pramod; Sabna Kotta; U S Jijith; A Aravind; M Abu Tahir; C S Manju; H V Gangadharappa
Journal:  Med Hypotheses       Date:  2020-07-07       Impact factor: 1.538

8.  Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy.

Authors:  Abul Bashar Mir Md Khademul Islam; Md Abdullah-Al-Kamran Khan
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.